RecallGuardianCanada
Radiopharmaceuticals· Updated November 9, 2023

Sabril (vigabatrin) 500 mg sachets and tablets found to contain trace amounts of another drug

Standard priority
Recalled product: Sabril (vigabatrin) 500 mg sachets and tablets found to contain trace amounts of another drug
What you should do
  1. 1Do not stop taking your Sabril medication without consulting your physician.
  2. 2Monitor for any new and unexpected side effects.
  3. 3Seek immediate medical attention of you experience symptoms of a severe allergic reaction, such as difficulty breathing or swallowing or severe swelling of the lips, mouth or throat.
  4. 4Consult your health care professional if you or your child are taking Sabril and you have any concerns.
  5. 5Report any health product-related side effects or complaints to Health Canada.
The issue

Contamination

Affected product

Sabril (vigabatrin) 500 mg sachets, DIN 02068036, lots 3209710A and 3207333A. UPDATED September and November 2023 to add additional lots/products (see table).

Where it was sold

Canada (national)Reported in the official notice — confirm there.

Issued by

Health Canada

Read the official Government of Canada notice

RecallGuardian ranks, illustrates and rewrites recalls in plain language. The official notice is authoritative — confirm model numbers, lot codes, dates and remedies there.

All recalls